Eris Lifesciences allotted 24,396 equity shares under its ESOP-2021 scheme on May 11, 2026.
The allotment was made at three different exercise prices ranging from ₹510.32 to ₹728.16 per share.
Paid-up share capital increased from ₹13.85 crore to ₹13.86 crore following the ESOP allotment.
The filing represents a regulatory compliance disclosure for capital structure changes under SEBI regulations.